Company: HURA
Filing Date: 2025-12-10
Form Type: 424B5
Source: 0001193125-25-313799
Chunk: 19

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-12-10
Form: 424B5
Chunk 19
---
 $15.6 million before deduction of placement agent commissions and offering expenses, in a best-efforts offering. There is no minimum amount of proceeds that is a condition to closing of this offering. We have engaged H.C. Wainwright & Co., LLC (“Wainwright”) to act as the exclusive lead placement agent and Rodman & Renshaw LLC as co-placementagent on a reasonable best-efforts basis, in connection with this offering pursuant to this prospectus supplement and accompanying prospectus. The placement agents are not purchasing or selling any of the securities offered by this prospectus supplement, nor are they required to arrange the purchase or sale of any specific number or dollar amount of securities, but have agreed to use their reasonable best efforts to arrange for the sale of all of the securities offered hereby. Therefore, we may not sell the entire amount of securities being offered. We entered into a securities purchase agreement directly with certain of the institutional investors, at the investor’s option, who purchased our securities in this offering The placement agents may engage one or more subagents or selected dealers in connection with this offering. We will deliver the securities being issued to the investors upon receipt of investor funds for the purchase of the securities offered pursuant to this prospectus supplement. We expect to deliver the securities being offered pursuant to this prospectus supplement on or about December 10, 2025, with delayed settlement and closing for K&V, which such closings are expected to occur no later than January 30, 2026 and February 27, 2026 for their respective tranches. We have agreed to indemnify the placement agents against specified liabilities, including liabilities under the Securities Act, and to contribute to payments the placement agents may be required to make in respect thereof. Placement Agent Fees, Commissions and Expenses We have agreed to pay the placement agents a fee equal to seven percent (7.0%) of the gross proceeds raised in this offering, provided that we shall pay the placement agents a reduced cash fee of 2.0% of the aggregate gross proceeds raised from the sale of the securities to K&V. In addition, we have agreed to reimburse the placement agents for certain of their expenses, including its reasonable fees and expenses of counsel in an amount not to exceed $100,000 and $25,000 for non-accountableexpenses. In addition, we have agreed to issue to the lead placement agent or its designees the Placement Agent Warrants to purchase that number of shares of our Common Stock equal to 3.0